Finance
Results: 433-444 of 45380

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate

GAC Group Named to Fortune Global 500 for 14 Consecutive Years, Highlighting Continued Global Growth

Results: 433-444 of 45380


